A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections

Clinical Microbiology and Infection

Volumn 16, Issue 8, 2010, Pages 1274-1281

  Towfigh, S ^a   Pasternak, J ^b   Poirier, A ^c   Leister, H ^d   Babinchak, T ^d  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Real e Benemérita Sociedade Portuguesa so BeneficAogonekncia   (Brazil)

^c Centre hospitalier regional de Trois Rivieres   (Canada)

^d PFIZER INC   (United States)

Author keywords

Antibiotic; Complicated intra abdominal infection; Glycylcycline; Metronidazole; Monotherapy ceftriaxone; Randomized trial; Tigecycline

Indexed keywords

CEFTRIAXONE; METRONIDAZOLE; TIGECYCLINE; ANTIINFECTIVE AGENT; MINOCYCLINE;

ABDOMINAL DISTENSION; ABDOMINAL INFECTION; ABSCESS; ADULT; ANEMIA; ANTIBIOTIC THERAPY; ANXIETY; APACHE; ARTICLE; ATELECTASIS; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; ERADICATION THERAPY; ESCHERICHIA COLI; FEMALE; FEVER; GENERALIZED EDEMA; HEADACHE; HEALING; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPOPROTEINEMIA; ILEUS; INFECTION; INFECTION COMPLICATION; INSOMNIA; LEUKOCYTOSIS; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; PERIPHERAL EDEMA; PHARYNGITIS; PLEURA EFFUSION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY FAILURE; SIDE EFFECT; TASTE DISORDER; THROMBOCYTOPENIA; THRUSH; TREATMENT OUTCOME; VOMITING; ABDOMEN; ANALOGS AND DERIVATIVES; BACTERIA; BACTERIAL INFECTIONS; COMPARATIVE STUDY; DRUG COMBINATION; GASTROINTESTINAL DISEASES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES;

ABDOMEN; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; CEFTRIAXONE; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; MINOCYCLINE; TREATMENT OUTCOME;

EID: 77955165641     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03122.x     Document Type: Article

References (13)

1. Dowzicky MJ, Park CH. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the united states: results from the tigecycline evaluation and surveillance trial (test) 2005 to 2007. Clin Ther 2008, 30:2040-2050.
2. Low DE, Markovic MJ, Dowzicky MJ. Antimicrobial susceptibility among bacterial isolates from icu and non-icu setting and different age groups: results from the tigecycline evaluation and surveillance trial in north america. J Chemother 2009, 21:16-23.
3. Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (gar-936). Antimicrob Agents Chemother 1999, 43:738-744.
4. Rossi F, Garcia P, Ronzon B, Curcio D, Dowzicky MJ. Rates of antimicrobial resistance in latin america (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis 2008, 12:405-415.
5. Fomin P, Beuran M, Gradauskas A. Tigecycline is efficacious in the treatment of complicated intra-abdominal infections. Int J Surg 2005, 3:35-47.
6. Oliva ME, Rekha A, Yellin A. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [study id numbers: 3074a1-301-ww; clinicaltrials. Gov identifier: Nct00081744]. BMC Infect Dis 2005, 5:88.
7. Mazuski JE, Solomkin JS. Intra-abdominal infections. Surg Clin North Am 2009, 89:421-437.
8. Inui T, Haridas M, Claridge JA, Malangoni MA. Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection. Surgery 2009, 146:654-661.
9. Pacelli F, Doglietto GB, Alfieri S. Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. Arch Surg 1996, 131:641-645.
10. Krobot K, Yin D, Zhang Q. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 2004, 23:682-687.
11. Cainzos M. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections - are they applicable today? Clin Microbiol Infect 2008, 14(suppl 6):9-18.
12. Solomkin J, Mazuski J, Baron E. Guidelines for the selection of anti-infective agent for complicated intra-abdominal infections. Clin Infect Dis 2003, 37:997-1005.
13. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 2005, 41(suppl 5):S354-S367.